Cite
HARVARD Citation
Ye, J. et al. (2022). Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. Journal for immunotherapy of cancer. 10 (7), p. . [Online].